1. Ribes JA, Vanover-Sams CL, Baker DJ Zygomycetes in human disease. Clin Microbio Rev. 2002; 13: 236-301. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
2. Chakrabarti A, Das A, Panda N, Das S, Gupta KL, Sakhuja V. Ten years' experience in zygomycosis at a tertiary care centre in India. J Infect. 2001; 42:261-6. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
3. Drouhet E, Ravisse P. Entomophthoromycosis. Curr Topical Med Mycol. 1993; 5: 215-245. [
PubMed]
4. Rogers TR. Treatment of Zygomycosis: current and new options. J Antimicrob Chemother. 2008; 61: 35-40. [
View at Publisher] [
DOI] [
PubMed] [
Google Scholar]
5. Ge Song, Guanzhao Liang, Weida Liu. Fungal Co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China .Mycopathologia. 2020; 185(4): 599-606. [
View at Publisher] [
DOI:10.1007/s11046-020-00462-9] [
PubMed] [
Google Scholar]
6. A. Skiada, I. Pavleas, M. Drogari-Apiranthitou. Epidemiology and diagnosis of mucormycosis: an Update J Fungi. 2020; 6(4): 265. [
View at Publisher] [
DOI:10.3390/jof6040265] [
PubMed] [
Google Scholar]
7. Chander J, Kaur M, Singla N. Mucormycosis: battle with the deadly enemy over a five-year period in India. J. Fungi. 2018; 4 (2):46. [
View at Publisher] [
DOI:10.3390/jof4020046] [
PubMed] [
Google Scholar]
8. Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi. 2019; 5(1): 26. [
View at Publisher] [
DOI:10.3390/jof5010026] [
PubMed] [
Google Scholar]
9. Avatef Fazeli M, Rezaei L, Javadirad E, Iranfar K, Khosravi A, Amini Saman J, et al. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study. Mycoses. 2021; 64: 1366- 1377. [
View at Publisher] [
DOI:10.1111/myc.13351] [
PubMed] [
Google Scholar]
10. Deutsch PG, Whittaker J, Prasad S. Invasive and non-invasive fungal rhinosinusitis-a review and update of the evidence. Medicina. 2019; 55(7):319. [
View at Publisher] [
DOI:10.3390/medicina55070319] [
PubMed] [
Google Scholar]
11. Sree Lakshmi I, Kumari BS, Jyothi C, Devojee M, Padma Malini K, Sunethri P, et al. Histopathological Study of Mucormycosis in Post COVID-19 Patients and Factors Affecting it in a Tertiary Care Hospital. Int J Surg Pathol. 2023; 31(1): 56-63. [
View at Publisher] [
DOI:10.1177/10668969221099626] [
PubMed] [
Google Scholar]
12. Chander J. Chander J. Fungal reagents and stainings. Textbook of Medical Mycology. 3rd ed. 2009. New Delhi Mehta. 514-521. [
View at Publisher] [
Google Scholar]
13. Gamble M. Bancroft DJ, Gamble M. The hematoxylin and eosin, Theory and Practice of Histological Techniques. 6th ed. 2008. New York Elsevier. 121-123. [
View at Publisher] [
DOI:10.1016/B978-0-443-10279-0.50016-6] [
Google Scholar]
14. MyersBR, FredenburghLJ, GrizzkWE, BancroftDJ, GambleM. Carbohydrates, Theory and Practice of Histological Techniques. 2008.6th ed. New York. Elsevier. 171
15. Bartlett JH. Bancroft DJ, Gamble M.. Microorganisms, Theory and Practice of Histological Techniques, 20086th ed New York Elsevier pg. 320
16. Hoang K, Abdo T, Reinersman JM, Lu R, Higuita NIA. A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patient. Med Mycol Case Rep. 2020; 29: 22-24. [
View at Publisher] [
DOI:10.1016/j.mmcr.2020.05.008] [
PubMed] [
Google Scholar]
17. Ferguson BJ. Definitions of fungal rhinosinusitis. Otolaryngol Clin North Am. 2000; 33: 227-35. [
View at Publisher] [
DOI:10.1016/S0030-6665(00)80002-X] [
PubMed] [
Google Scholar]
18. Granville L, Chirala M, Cernoch P, Ostrowski M, Truong LD. Fungal sinusitis: Histologic spectrum and correlation with culture. Hum Pathol 2004;35:474-81. [
View at Publisher] [
DOI:10.1016/j.humpath.2003.10.024] [
PubMed] [
Google Scholar]
19. Abedi E, Sismanis A, Choi K, Pastore Pl. Twenty-five years' experience treating cerebro-rhino-orbital mucormycosis. Laryngoscope. 1984;94:1060-2. [
View at Publisher] [
DOI:10.1288/00005537-198408000-00013] [
PubMed] [
Google Scholar]
20. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in RhinoOrbito-cerebral Mucormycosis. Surg Ophthal. 1994; 39:3-20. [
View at Publisher] [
DOI:10.1016/S0039-6257(05)80041-4] [
PubMed] [
Google Scholar]
21. Goel A, Kini U, Shetty S. Role of histopathology as an aid to prognosis in rhino-orbito-cerebral zygomycosis. Indian J Pathol Microbiol. 2010; 53: 253-7. [
View at Publisher] [
DOI:10.4103/0377-4929.64342] [
Google Scholar]
22. Frater JL, Hall GS, Procop GW. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med. 2001;125:375-8. [
View at Publisher] [
DOI:10.5858/2001-125-0375-HFOZ] [
Google Scholar]
23. Castillo L, Hofman V, Betis F, Piche M, Roger PM, Santini J, et al. Longterm survival in acute rhinocerebral mucormycosis with giant cell arteritis and foreign body granulomas. Pathol Res Pract. 2001;197:199-203. [
View at Publisher] [
DOI:10.1078/0344-0338-00034] [
Google Scholar]
24. Yu B, Li X, Chen J, Ouyang M, Zhang H, Zhao X, et al. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J Thromb Thrombolysis. 2020; 50(3): 548-557. [
View at Publisher] [
PubMed] [
Google Scholar]
25. Banchini F, Cattaneo GM, Capelli P. Serum ferritin levels in inflammation: a retrospective comparative analysis between COVID-19 and emergency surgical non-COVID-19 patients. World J Emerg Surg. 2021; 16(1): 9. [
View at Publisher] [
DOI:10.1186/s13017-021-00354-3] [
PubMed] [
Google Scholar]
26. John TM, Jacob CN, Kontoyiannis DP. When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J Fungi (Basel). 2021; 7(4): 298. [
View at Publisher] [
DOI:10.3390/jof7040298] [
PubMed] [
Google Scholar]